A crucial battle is unfolding in the US Supreme Court, with far-reaching implications for reproductive rights nationwide. Louisiana is set to argue before the nation's highest court that mail-order mifepristone, a medication used in medical abortions, should be subject to stricter regulations and potentially even banned. The state's move is aimed at circumventing the federal approval process, which has allowed women to access the medication through mail-order services despite state-level abortion bans. If Louisiana succeeds, it could effectively shut down the lifeline for thousands of women who rely on mail-order mifepristone to exercise their reproductive rights, sparking a national debate on the limits of federal authority and the future of abortion access in the United States.
Mail-order mifepristone is how countless women bypass abortion bans. That could soon change if Louisiana gets its way before the Supreme Court.